| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Protalix BioTherapeutics Inc (TA: PLX)
PLX Technical Analysis
5
| As on 20th Mar 2023 PLX SHARE Price closed @ 732.50 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 346.04 & Strong Buy for SHORT-TERM with Stoploss of 351.99 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PLXSHARE Price
| Open | 725.00 | Change | Price | % |
| High | 738.70 | 1 Day | 7.00 | 0.96 |
| Low | 703.00 | 1 Week | -35.50 | -4.62 |
| Close | 732.50 | 1 Month | 162.50 | 28.51 |
| Volume | 105597 | 1 Year | 308.20 | 72.64 |
| 52 Week High 780.00 | 52 Week Low 252.50 | ||||
TA Israel Most Active Stocks
| TA125 | 2008.05 | 1.06% |
| BLRX | 2.70 | 12.50% |
| GNRS | 91.00 | 4.84% |
| MGDL | 759.00 | -0.93% |
| ALMO | 36.10 | 58.33% |
| GIX | 36.10 | 58.33% |
| BEZQ | 557.00 | 0.36% |
| CANF | 1.40 | 0.00% |
| DSCT | 2968.00 | 1.75% |
| LUMI | 5671.00 | 2.20% |
TA Israel Top Gainers Stocks
TA Israel Top Losers Stocks
| PLX Daily Charts |
PLX Intraday Charts |
Whats New @ Bazaartrend |
PLX Free Analysis |
|
|
PLX Important Levels Intraday
| RESISTANCE | 801.29 |
| RESISTANCE | 779.23 |
| RESISTANCE | 765.59 |
| RESISTANCE | 751.96 |
| SUPPORT | 713.04 |
| SUPPORT | 699.41 |
| SUPPORT | 685.77 |
| SUPPORT | 663.71 |
PLX Forecast June 2025
| 4th UP Forecast | 950.06 |
| 3rd UP Forecast | 880.29 |
| 2nd UP Forecast | 837.16 |
| 1st UP Forecast | 794.03 |
| 1st DOWN Forecast | 670.97 |
| 2nd DOWN Forecast | 627.84 |
| 3rd DOWN Forecast | 584.71 |
| 4th DOWN Forecast | 514.94 |
PLX Weekly Forecast
| 4th UP Forecast | 892.25 |
| 3rd UP Forecast | 841.02 |
| 2nd UP Forecast | 809.35 |
| 1st UP Forecast | 777.68 |
| 1st DOWN Forecast | 687.32 |
| 2nd DOWN Forecast | 655.65 |
| 3rd DOWN Forecast | 623.98 |
| 4th DOWN Forecast | 572.75 |
PLX Forecast2025
| 4th UP Forecast | 1755.74 |
| 3rd UP Forecast | 1427.58 |
| 2nd UP Forecast | 1224.74 |
| 1st UP Forecast | 1021.9 |
| 1st DOWN Forecast | 443.11 |
| 2nd DOWN Forecast | 240.26 |
| 3rd DOWN Forecast | 37.42 |
| 4th DOWN Forecast | -290.74 |
Protalix BioTherapeutics Inc ( TA Israel Symbol : PLX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PLX Business Profile
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in Israel, Brazil, rest of Latin America, and internationally. The company offers Elelyso for the treatment of Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candidate, which is in phase III clinical trials for the treatment of Fabry diseases; PRX-110, a proprietary plant cell recombinant form of human deoxyribonuclease I that has completed phase IIa clinical trials for the treatment of cystic fibrosis; PRX-115, a plant cell-expressed recombinant PEGylated Uricase for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz (Fiocruz); and Chiesi Farmaceutici S.p.A. The company was founded in 1993 and is based in Hackensack, New Jersey. Address: 2 University Plaza, Hackensack, NJ, United States, 07601
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service